Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron: a drug developer’s perspective
Fang Fang, Pei‐Yong Shi
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 208-211
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 97
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1987-1987
Open Access | Times Cited: 55
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 41
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 22
Molecular detection of SARS‐CoV‐2 and differentiation of Omicron and Delta variant strains
Wai Ning Tiffany Tsui, Vaughn Hamill, Lance W. Noll, et al.
Transboundary and Emerging Diseases (2022) Vol. 69, Iss. 5
Open Access | Times Cited: 19
Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
Md. Rabiul Islam, Waheeda Nasreen, Ramisa Anjum, et al.
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 18
SGCLMD: Signed graph-based contrastive learning model for predicting somatic mutation-drug association
Xiaosong Wang, Haisong Feng, Yilei Zhang, et al.
Computers in Biology and Medicine (2025) Vol. 190, pp. 110067-110067
Closed Access
Role of Omicron variant of SARS-CoV-2 in children in Germany
Stefan Bittmann
World Journal of Pediatrics (2022) Vol. 18, Iss. 4, pp. 283-284
Open Access | Times Cited: 14
Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections
Michael Y.T. Chow, Harry W. Pan, Han Cong Seow, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 2, pp. 85-97
Open Access | Times Cited: 14
Prevalence of taste and smell dysfunction in mild and asymptomatic COVID-19 patients during Omicron prevalent period in Shanghai, China: a cross-sectional survey study
Jia Wang, Yan Chen, Jing Huang, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e067065-e067065
Open Access | Times Cited: 6
Multi‐omic and comparative analyses revealed monocyte‐derived alpha‐defensin‐1 correlated with COVID‐19 severity and inhibited SARS‐CoV‐2 infection
Xijing Qian, Bingan Wu, X. Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 6
Forecast of Omicron Wave Time Evolution
R. Schlickeiser, Martin Kröger
COVID (2022) Vol. 2, Iss. 3, pp. 216-229
Open Access | Times Cited: 8
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody
Xiaoling Cao, Junjie Zai, Zhao Qing-zhen, et al.
Vaccine (2022) Vol. 40, Iss. 40, pp. 5757-5763
Open Access | Times Cited: 6
BA.2.12.1 is a new omicron offshoot that is a highly contagious but not severe disease
Ali Beheshti Namdar, Masoud Keikha
Annals of Medicine and Surgery (2022) Vol. 79
Open Access | Times Cited: 5
As the virus evolves, so too must we: a drug developer’s perspective
Fang Fang
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?
Igor José dos Santos Nascimento, Ricardo Olímpio de Moura
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 405-412
Closed Access | Times Cited: 4
Sotrovimab use in Japanese inpatients with COVID-19: post-infusion adverse events
Junichi Yoshida, Kenichiro Shiraishi, Masao Tanaka
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 3
SARS COV-2 DELTA VARIANT STRUCTURAL PROTEINS: HOMOLOGY WITH OPPORTUNISTIC BACTERIA
Александр Тимурович Марьянович, Дмитрий Юрьевич Кормилец
Russian Biomedical Research (2024) Vol. 9, Iss. 2, pp. 5-17
Open Access
The Knowledge and Attitude of Parents About the Dental Treatment of Their Children During the New Type of Coronavirus Outbreak in Northern Cyprus
Ayse Ekinci, Özgür Tosun, Aylin İslam
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 2
The Concomitant Use o f Melatonin and Bebtelovimab as a Treatment Strategy for Omicron and Future Variants of Concern
Emine Erdag
International Journal Of Pharmaceutical Research And Allied Sciences (2022) Vol. 11, Iss. 4, pp. 33-40
Open Access | Times Cited: 2
Sotrovimab neutralizing SARS-CoV-2: Risk factors for post-infusion clinical events
Junichi Yoshida, Kenichiro Shiraishi, Hirotaka Noda, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top